Mathiéu Molimard

11.3k total citations · 1 hit paper
250 papers, 7.9k citations indexed

About

Mathiéu Molimard is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Mathiéu Molimard has authored 250 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 75 papers in Physiology and 37 papers in Molecular Biology. Recurrent topics in Mathiéu Molimard's work include Asthma and respiratory diseases (72 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Chronic Myeloid Leukemia Treatments (30 papers). Mathiéu Molimard is often cited by papers focused on Asthma and respiratory diseases (72 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Chronic Myeloid Leukemia Treatments (30 papers). Mathiéu Molimard collaborates with scholars based in France, United Kingdom and United States. Mathiéu Molimard's co-authors include Nicholas Moore, Karine Titier, Vincent Gros, Stéphane Bouchet, François‐Xavier Mahon, Dominique Ducint, Mario Cazzola, Chantal Rahérison, Charles Advenier and Bernard Bégaud and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Mathiéu Molimard

238 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

2010 674 citations David Marín, Alexandra Bazeos et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathiéu Molimard France	47	2.7k	2.3k	2.0k	1.7k	1.0k	250	7.9k
Jack F.M. Wetzels Netherlands	66	2.8k 1.0×	719 0.3×	1.5k 0.8×	1.3k 0.8×	3.4k 3.3×	394	14.3k
Peter Höglund Sweden	51	3.0k 1.1×	1.3k 0.5×	356 0.2×	987 0.6×	1.3k 1.3×	236	8.9k
Robert C. Atkins Australia	68	2.2k 0.8×	1.4k 0.6×	607 0.3×	498 0.3×	2.8k 2.7×	243	18.3k
Danilo Fliser Germany	75	2.3k 0.8×	2.3k 1.0×	1.3k 0.7×	588 0.3×	4.0k 4.0×	301	18.6k
Richard J. Glassock United States	60	2.5k 0.9×	786 0.3×	715 0.4×	571 0.3×	2.0k 2.0×	261	12.8k
Barry I. Freedman United States	65	1.3k 0.5×	1.4k 0.6×	434 0.2×	1.3k 0.8×	3.3k 3.2×	420	16.3k
Ted P. Szatrowski United States	26	2.0k 0.7×	662 0.3×	1.5k 0.8×	1.1k 0.6×	1.7k 1.7×	41	10.9k
Steven Fishbane United States	45	1.6k 0.6×	590 0.3×	3.5k 1.8×	1.9k 1.1×	1.6k 1.6×	179	10.1k
Frank Ruschitzka Switzerland	61	2.7k 1.0×	1.6k 0.7×	1.4k 0.7×	518 0.3×	1.9k 1.8×	384	21.4k
David A. Roth United States	47	2.9k 1.1×	1.3k 0.6×	1.4k 0.7×	700 0.4×	2.3k 2.3×	212	20.6k

Countries citing papers authored by Mathiéu Molimard

Since Specialization

Citations

This map shows the geographic impact of Mathiéu Molimard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathiéu Molimard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathiéu Molimard more than expected).

Fields of papers citing papers by Mathiéu Molimard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathiéu Molimard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathiéu Molimard. The network helps show where Mathiéu Molimard may publish in the future.

Co-authorship network of co-authors of Mathiéu Molimard

This figure shows the co-authorship network connecting the top 25 collaborators of Mathiéu Molimard. A scholar is included among the top collaborators of Mathiéu Molimard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathiéu Molimard. Mathiéu Molimard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berdaï, Driss, David Pérol, Mathiéu Molimard, et al.. (2024). Ethics and clinical research: How can the Ethics Committees (CPPs) and Committees for Research Ethics (CER) evolve?. Therapies. 80(1). 145–154.

Demoly, Pascal, Mathiéu Molimard, Jean‐François Bergmann, et al.. (2024). Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study). The Lancet Regional Health - Europe. 41. 100915–100915. 12 indexed citations

Villa, Antoine, et al.. (2023). Factors associated with internal contamination of nurses by antineoplastic drugs based on biomonitoring data from a previous study. International Journal of Hygiene and Environmental Health. 254. 114264–114264. 3 indexed citations

Lemaı̂tre, F., Matthieu Grégoire, Caroline Monchaud, et al.. (2022). Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT). Therapies. 77(5). 509–521. 40 indexed citations

Noïze, Pernelle, et al.. (2020). Safety profile of drugs for advanced melanoma: A report based on 2008–2018 US Food and Drug Administration Data. British Journal of Clinical Pharmacology. 87(7). 2988–2995. 1 indexed citations

Noïze, Pernelle, Amandine Gouverneur, Driss Berdaï, et al.. (2020). Overview of French databases available for studying anticancer drugs in real‐life setting. Fundamental and Clinical Pharmacology. 35(1). 76–85. 8 indexed citations

Villa, Antoine, et al.. (2019). Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study. BMJ Open. 9(11). e033040–e033040. 5 indexed citations

Molimard, Mathiéu & Paul Colthorpe. (2014). Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(3). 219–228. 72 indexed citations

Brossaud, Julie, et al.. (2012). Urinary cortisol metabolites in corticotroph and adrenal tumours. 15th International & 14th European Congress of Endocrinology. 29. 5 indexed citations

10.

Marín, David, Alexandra Bazeos, François-Xavier Mahon, et al.. (2010). Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib. Journal of Clinical Oncology. 28(14). 2381–2388. 674 indexed citations breakdown →

11.

Molimard, Mathiéu, Vincent Gros, Philip Robinson, & I. Bourdeix. (2009). Prevalence and Associated Factors of Oropharyngeal Side Effects in Users of Inhaled Corticosteroids in a Real-Life Setting. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(2). 91–95. 17 indexed citations

12.

Picard, Stéphane, Karine Titier, Gabriel Étienne, et al.. (2006). Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 109(8). 3496–3499. 468 indexed citations

13.

Naline, Emmanuel, A. Trifilieff, Robin A. Fairhurst, Charles Advenier, & Mathiéu Molimard. (2006). Effect of indacaterol, a novel long-acting β₂-agonist, on isolated human bronchi. European Respiratory Journal. 29(3). 575–581. 81 indexed citations

14.

Molimard, Mathiéu. (2005). How to achieve good compliance and adherence with inhalation therapy. Current Medical Research and Opinion. 21(sup4). S33–S37. 38 indexed citations

15.

Molimard, Mathiéu, et al.. (2005). Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. Respiratory Medicine. 99(6). 770–778. 31 indexed citations

16.

Berger, Patrick, François Laurent, Hugues Bégueret, et al.. (2003). Structure and Function of Small Airways in Smokers: Relationship between Air Trapping at CT and Airway Inflammation. Radiology. 228(1). 85–94. 44 indexed citations

17.

Degano, Bruno, Patrick Berger, Mathiéu Molimard, et al.. (2001). Estradiol Decreases the Acetylcholine-elicited Airway Reactivity in Ovariectomized Rats through an Increase in Epithelial Acetylcholinesterase Activity. American Journal of Respiratory and Critical Care Medicine. 164(10). 1849–1854. 54 indexed citations

18.

Zhang, Yong, Joëlle Moreau, Mathiéu Molimard, et al.. (1998). Contractile effect of 6 beta-acetoxy nortropane on human and guinea pig airways.. PubMed. 19(3). 211–7. 1 indexed citations

19.

Molimard, Mathiéu, et al.. (1998). Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi. European Respiratory Journal. 11(3). 583–588. 46 indexed citations

20.

Molimard, Mathiéu, et al.. (1996). Indirect muscarinic receptor activation by pentamidine on airway smooth muscle. British Journal of Pharmacology. 119(6). 1131–1136. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact